DE69103068T2 - Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält. - Google Patents

Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.

Info

Publication number
DE69103068T2
DE69103068T2 DE69103068T DE69103068T DE69103068T2 DE 69103068 T2 DE69103068 T2 DE 69103068T2 DE 69103068 T DE69103068 T DE 69103068T DE 69103068 T DE69103068 T DE 69103068T DE 69103068 T2 DE69103068 T2 DE 69103068T2
Authority
DE
Germany
Prior art keywords
alpha
phenyl
therapeutic agent
urinary incontinence
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69103068T
Other languages
German (de)
English (en)
Other versions
DE69103068D1 (de
Inventor
Masaaki Tomoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69103068D1 publication Critical patent/DE69103068D1/de
Publication of DE69103068T2 publication Critical patent/DE69103068T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE69103068T 1990-04-18 1991-04-11 Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält. Expired - Fee Related DE69103068T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10390390 1990-04-18

Publications (2)

Publication Number Publication Date
DE69103068D1 DE69103068D1 (de) 1994-09-01
DE69103068T2 true DE69103068T2 (de) 1995-01-05

Family

ID=14366388

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69103068T Expired - Fee Related DE69103068T2 (de) 1990-04-18 1991-04-11 Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.

Country Status (11)

Country Link
US (1) US5202331A (enExample)
EP (1) EP0452809B1 (enExample)
JP (1) JP2500821B2 (enExample)
KR (1) KR100190823B1 (enExample)
AT (1) ATE109003T1 (enExample)
AU (1) AU641747B2 (enExample)
CA (1) CA2040680A1 (enExample)
DE (1) DE69103068T2 (enExample)
DK (1) DK0452809T3 (enExample)
TW (1) TW214546B (enExample)
ZA (1) ZA912589B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002432A1 (en) * 1996-07-16 1998-01-22 Takeda Chemical Industries, Ltd. Bicyclic compounds for controlling micturition
EP1293206A4 (en) * 2000-05-15 2005-09-21 Kissei Pharmaceutical LIQUID PREPARATION BASED ON WATER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980664A (ja) * 1982-09-30 1984-05-10 Fujisawa Pharmaceut Co Ltd α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
US4857535A (en) * 1986-01-09 1989-08-15 United Pharmaceuticals Anti-spasmodic agents having a heterocyclic ring
DE3601196A1 (de) * 1986-01-17 1987-07-23 Merck Patent Gmbh 1,4-dihydropyridine
US4957941A (en) * 1987-11-16 1990-09-18 United Pharmaceuticals, Inc. Anti-spasmdoic agents having an acetylenic bond
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
US5202331A (en) 1993-04-13
CA2040680A1 (en) 1991-10-19
KR910018026A (ko) 1991-11-30
ZA912589B (en) 1992-01-29
AU7506591A (en) 1991-10-24
AU641747B2 (en) 1993-09-30
KR100190823B1 (ko) 1999-06-01
EP0452809A2 (en) 1991-10-23
ATE109003T1 (de) 1994-08-15
DK0452809T3 (da) 1994-09-05
EP0452809B1 (en) 1994-07-27
DE69103068D1 (de) 1994-09-01
JPH059118A (ja) 1993-01-19
JP2500821B2 (ja) 1996-05-29
TW214546B (enExample) 1993-10-11
EP0452809A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
EP2789617B1 (en) Method of preparation of Enantiomers of spiro-oxindole compounds
KR100967070B1 (ko) 아세트산 아닐리드 유도체를 유효성분으로 하는 과활동방광 치료제
US20090270455A1 (en) Therapeutic agent for intestinal diseases and visceral pain
US20090105298A1 (en) Pharmaceutical composition for therapy of interstitial cystitis
JP2002053566A (ja) チアゾール化合物及びその医薬用途
DD155991A5 (de) Verfahren zur herstellung von imidazolin-derivaten
US20260001872A1 (en) Benzisothiazole compound and application thereof, and pharmaceutical composition and application thereof
WO2008080955A1 (en) Isosorbide mononitrate derivatives for the treatment of intestinal disorders
AT391320B (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
EP1872795A1 (en) Therapeutic agent for irritable bowel syndrome
DE69015834T2 (de) 6-Chlor-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzodiazepin-carbamate als Pro-Arzneimittel.
US5202331A (en) Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
US7354949B2 (en) Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
US20060160887A1 (en) Medicinal composition
DE68915595T2 (de) Verwendung von Isoxazolinonen als cerebro-aktive Medikamente.
HUP0303609A2 (hu) Húgyhólyag-túlérzékenység kezelésére alkalmas készítmény
WO2005055999A1 (ja) 抗コリン作用剤
US20050130982A1 (en) Oral therapeutic or preventative drugs for pollakiuria and urinary incontinence and oral sleep inducers, containing tropolone derivatives
JPH035425A (ja) 抗潰瘍剤
JPH03130218A (ja) 子宮弛緩剤及び膀胱弛緩剤
JPS6013714A (ja) 胃腸細胞保護剤
JPH0211568A (ja) ２―ピリジル酢酸誘導体
JPH09124487A (ja) 腎臓疾患予防・治療剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee